322692-47-7

Basic information

• Product Name: 1,1-dimethylethyl (5-bromo-2,3-dihydro-1H-inden-2-yl)carbamate
• Synonyms: 1,1-dimethylethyl (5-bromo-2,3-dihydro-1H-inden-2-yl)carbamate
• CAS NO: 322692-47-7
• Molecular Weight: 312.206
• Mol File: 322692-47-7.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 396.6±42.0 °C(Predicted)
• Density: 1.37±0.1 g/cm3(Predicted)
• CAS DataBase Reference: 1,1-dimethylethyl (5-bromo-2,3-dihydro-1H-inden-2-yl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: 1,1-dimethylethyl (5-bromo-2,3-dihydro-1H-inden-2-yl)carbamate(322692-47-7)
• EPA Substance Registry System: 1,1-dimethylethyl (5-bromo-2,3-dihydro-1H-inden-2-yl)carbamate(322692-47-7)

Safety Data

• Hazardous Substances Data: 322692-47-7(Hazardous Substances Data)

Usage

Functional groups

Carbamate derivative, 5-bromo-2,3-dihydro-1H-inden-2-yl group

Structure

Contains a 5-bromo-2,3-dihydro-1H-inden-2-yl group attached to a 1,1-dimethylethyl carbamate

Applications

Potential use in pharmaceuticals and agrochemicals

Synthesis

May be used as an intermediate in the synthesis of various organic compounds

Reactivity

Specific reactivity due to its unique structure

Biological activity

Interesting target for research and development due to its potential biological activity

Further research

Studies needed to fully understand potential uses and effects of the compound

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 321352-52-7 5-bromo-2-aminoindane hydrobromide 
• 73536-88-6 5-bromo-2-aminoindane 
• 2338-18-3 2-aminoindane hydrochloride 
• 2975-41-9 2,3-dihydro-1H-inden-2-amine 

Downstream Products

• 1289202-95-4 (N-[5-(1-ethyl-3-(4-trifluoromethylphenoxy)-1H-pyrazol-5-yl)-2,3-dihydro-1H-inden-2-yl]-N'-(2,2,2-trifluoroethyl)sulfuric diamide) 
• 1289203-67-3 5-{1-ethyl-3-[4-(trifluoromethyl)phenoxy]-1H-pyrazol-5-yl}-2,3-dihydro-1H-inden-2-amine 
• 1007579-51-2 1,1-dimethylethyl {5-[3-(aminocarbonyl)phenyl]-2,3-dihydro-1H-inden-2-yl}carbamate 

Relevant articles and documents

MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN

Disclosed herein are compounds and compositions having potency in the modulation of Myc family proteins. Such compounds and compositions can be used in the treatment of proliferative diseases, such as cancer, or in the treatment of disease where modulation of Myc family proteins is desired. Also disclosed herein are methods of using said compounds and compositions.

ANTIBACTERIAL COMPOUNDS

This invention relates to antibacterial and anti-mycobacterial drug compounds of formula (I). It also relates to pharmaceutical formulations of antibacterial drug compounds of formula (I). It also relates to uses of the derivatives in treating bacterial i

SUBSTITUTED CYCLIC COMPOUNDS AND METHODS OF USE

The present invention provides novel substituted alkynyl compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.